SCHEMBL7975265

SCHEMBL7975265

O=c1[nH]c(-c2ccccc2)nc2ncn(Cc3ccccc3)c12

nearest known ligand 0.61

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.61
ALDH1A1 P00352 2/20 0.61
KMT2A Q03164 2/20 0.60
HPGD P15428 1/20 0.57
ADORA3 P0DMS8 2/20 0.49
PNP P00491 2/20 0.47
PARN O95453 1/20 0.47
CNOT7 Q9UIV1 1/20 0.47
BRD4 O60885 1/20 0.46
GAA P10253 1/20 0.43
ADORA2B P29275 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
TNKS O95271 1/20 0.42
PARP1 P09874 1/20 0.42
TNKS2 Q9H2K2 1/20 0.42
MEN1 O00255 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7974445 0.93 ALDH1A1 (0.56) SMN1; SMN2ALDH1A1KMT2AHPGDADORA3
SCHEMBL7991402 0.93 SMN1; SMN2 (0.54) SMN1; SMN2ALDH1A1KMT2AHPGDADORA3
SCHEMBL7984453 0.93 ALDH1A1 (0.56) SMN1; SMN2ALDH1A1KMT2AHPGDADORA3
SCHEMBL7975129 0.93 SMN1; SMN2 (0.56) SMN1; SMN2ALDH1A1KMT2AHPGDADORA3
SCHEMBL7974505 0.92 SMN1; SMN2 (0.55) SMN1; SMN2ALDH1A1KMT2AHPGDADORA3
SCHEMBL7984716 0.92 SMN1; SMN2 (0.53) SMN1; SMN2ALDH1A1KMT2AHPGDADORA3
SCHEMBL7988556 0.92 SMN1; SMN2 (0.58) SMN1; SMN2ALDH1A1KMT2AHPGDADORA3
Hydrochloric Acid SCHEMBL7985511 0.92 SMN1; SMN2 (0.55) SMN1; SMN2ALDH1A1KMT2AHPGDADORA3
SCHEMBL7986518 0.92 SMN1; SMN2 (0.53) SMN1; SMN2ALDH1A1KMT2AHPGDADORA3
SCHEMBL7988662 0.91 SMN1; SMN2 (0.53) SMN1; SMN2ALDH1A1KMT2AHPGDADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed
EP-0538332-A1 POLYCYCLIC GUANINE DERIVATIVES. SCHERING CORP (US) 1993-04-28 EP disclosed